The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Democrats’ midterm push clouded by infighting over party keeping 2024 autopsy under wraps
New 9/11 Museum exhibit aims to connect younger Americans to the attacks through powerful artifacts
Trump and Cabinet officials welcomed by Xi at China’s Great Hall of the People
CIA Accused of Raiding Tulsi Gabbard’s Office Seizing JFK, MKUltra Documents Set for Declassification
Trump’s upbeat China message collides with deepening Beijing rivalry
China rolls out red carpet for Trump as Xi meeting tests trade, Taiwan tensions
AG aims to retry Alex Murdaugh ‘quickly’; both sides enter courtroom chess match with each other’s game plans
California death row inmates watching porn on taxpayer-funded tablets, evading security controls: report
It never ends: GOP moves to fund border, Democrats blast Trump spending
Howard Lutnick testified he saw Epstein’s massage table as ‘sexual in nature’ during 2005 visit
Texas AG Paxton demands Dallas sheriff pursue ICE agreement as deadline dispute sparks legal threat
Video: Ex-Trans Speaker Postpones TPUSA Speech as Antifa ‘Militia … on Cross-Sex Hormones’ Threatens Violence Cops Weren’t Prepared for
Missouri man’s explosives tutorial helped New Orleans terrorist plan NYE attack, feds say
Vance turns up heat on states with federal cash threat over Medicaid fraud crackdown
JD Vance’s Fraud Task Force Makes California Pay $1.3 Billion Price for Defrauding Taxpayers
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
Democrats’ midterm push clouded by infighting over party keeping 2024 autopsy under wraps
New 9/11 Museum exhibit aims to connect younger Americans to the attacks through powerful artifacts
Trump and Cabinet officials welcomed by Xi at China’s Great Hall of the People
CIA Accused of Raiding Tulsi Gabbard’s Office Seizing JFK, MKUltra Documents Set for Declassification
Trump’s upbeat China message collides with deepening Beijing rivalry
China rolls out red carpet for Trump as Xi meeting tests trade, Taiwan tensions
AG aims to retry Alex Murdaugh ‘quickly’; both sides enter courtroom chess match with each other’s game plans
California death row inmates watching porn on taxpayer-funded tablets, evading security controls: report
It never ends: GOP moves to fund border, Democrats blast Trump spending
Howard Lutnick testified he saw Epstein’s massage table as ‘sexual in nature’ during 2005 visit
Texas AG Paxton demands Dallas sheriff pursue ICE agreement as deadline dispute sparks legal threat
Video: Ex-Trans Speaker Postpones TPUSA Speech as Antifa ‘Militia … on Cross-Sex Hormones’ Threatens Violence Cops Weren’t Prepared for
Missouri man’s explosives tutorial helped New Orleans terrorist plan NYE attack, feds say
Vance turns up heat on states with federal cash threat over Medicaid fraud crackdown
JD Vance’s Fraud Task Force Makes California Pay $1.3 Billion Price for Defrauding Taxpayers
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
